A Dose-Finding Study of Topiramate (JNS019) in Participants With Migraine

NCT01081795 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Topiramate
DRUG: Placebo

Sponsor

Janssen Pharmaceutical K.K.